Detailed Programme2018-11-12T14:37:38+00:00

Detailed Programme

as per November 7, 2018

Programme Overview
Programme for Saturday

Friday, November 23, 2018

8:15 – 8:20

Welcome Address

P.Bernecker

8:20 – 09:50

Session 1
Bone remodeling

Chairs: K. Klaushofer, E. Wagner

S01.1
08:20-08:50

A. Teti: Bone remodeling and the pathophysiology of bone diseases

Oral presentations from selected abstracts:

S01.2
N. Rucci: Role of Pre-proenkephalin 1 in the response of bone to mechanical unloading and in osteoblast differentiation
S01.3
M. Rauner: Dickkopf-1 (Dkk1) plays distinct pathogenic roles in estrogen-deficiency vs. glucocorticoid-induced bone loss
S01.4
H. Agis: The impact of PHD2 on dental and periodontal phenotype
S01.5
D. Pahr: Bone density frequency models – new insights into age, sex and treatment related changes
S01.6
U. Schwarze: Size Difference in miR-21 Knockout Mice: Geometrics Morphometrics on Teeth, Alveolar Bone and Mandible

09:50 – 10:20 Coffee Break
10:20 – 12:00

Session 2
Oral presentations from selected abstracts – basic research

Chairs: P. Pietschmann, A. Teti

S02.1
F. Lademann: Osteoprogenitor-specific versus global Mct8 knockout distinctly affects bone mass and turnover of male mice
S02.2
A. Blufstein: Effect of calcitriol on osteogenic differentiation of human periodontal ligament stem cells is altered under inflammatory conditions
S02.3
V. Wittner: Hierarchical Elastoplasticity of Bone
S02.4
K. Arvai: Effect of ovariectomy and selective estrogen receptor beta agonist treatment on gene expression of rat bone and bone marrow
S02.5
N. Hassler: Influence of shear forces on expression of stress related genes in osteoblast like MC3T3-E1 cells
S02.6
A. Raimann: Elevated phosphate levels impair skeletal muscle cell differentiation in vitro
S02.7
M. Černá: Polymorphisms in the Calcium-Sensing Receptor Gene in Diabetes Mellitus
S02.8
U. Föger-Samwald: Development of peak bone mass and muscle mass in inbred mouse strains: a pilot study

12:00 – 13:00 Lunch Break
13:00 – 14:00

Satellite Symposium Alexion: Beyond common Bone Diseases

R. Kocijan : Clinical and genetic management of rare bone diseases
H. Resch: Hypophosphatasia in Austria – Experience from a large patient cohort

14:00 – 15:30

Session 3
Treatment of osteoporosis

Chairs: H.P. Dimai, R. Thakker

S03.1
14:00-14:30
C. Cooper: Osteoporosis treatment: closing the gap
Oral presentations from selected abstracts:
S03.2
C. Muschitz: Teriparatide accelerates proximal humerus fracture consolidation – the TERAFRAP study
S03.3
M. Behanova: Antiresorptive treatment either with bisphosphonates or denosumab reduces mortality in hip fracture patients
S03.4
O. Malle: Mind the gap: Treatment rate after an osteoporotic fracture – results of the Austrian branch of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)
S03.5
A. Kurth: Treatment deficits after osteoporotic fractures – A regional analysis in the Rhine-Main-Area
S03.6
M. Hackl: Time-dependent analysis of circulating microRNAs and bone microstructure following anti-osteoporotic treatment in ovariectomized rats

14:30 – 15:30

Meet the Expert: J. Grillari

microRNAs in bone research

15:30 – 16:00 Coffee Break
16:00 – 17:00

Guided Poster Session 1

16:00 – 17:00

Meet the Expert: Barbara Obermayer-Pietsch

Bone Biochemical Markers

17:00 – 17:30

Award Ceremony
International Research Prize 2018

Michael P. Whyte

Chairs: K. Klaushofer, P. Bernecker

17:30 – 19:00

Session 4
Osteoimmunology and Traslational Research

Chairs: K. Kerschan-Schindl, H. Takayanagi

S04.1

17:30-18:00
G. Schett: Interactions between the immune and skeletal systems
Oral presentations from selected abstracts:

S04.2
N. Fratzl-Zelman: Metabolic overactive bone in Melorheostosis lesions caused by somatic activating mutations in MAP2K1
S04.3
T. Elajnaf: Investigating the effects of CaSR allosteric modulators on DSS-induced inflammation
S04.4
S. Blouin: Microarchitecture diversity in surrounding area of the standard transiliac biopsy site
S04.5
I. Foessl: Bone-and vessel-associated microRNA changes as potential pathomechanisms in chronic kidney disease
S04.6
B. Obermayer-Pietsch: Plasma non-oxidized PTH concentrations are affected by vitamin D supplementation

Saturday, November 24, 2018

08:00 – 09:20

Session 5
Osteooncology

Chairs: C. Muschitz, G. Pfeiler

S05.1

08:00-08:30
L. Hofbauer: Cancer and bone

Oral presentations from selected abstracts:
S05.2
K. Matsuoka: The role of non-canonical Wnt signalling in Osteosarcoma formation
S05.3
M. Linder: EGFR is required for FOS-dependent bone tumor development via RSK2/CREB signaling
S05.4
W. Brozek: Bone mineral density in early post-menopausal women does not predict breast cancer risk and mortality: a long-term follow-up study
S05.5
A. Kurth: STAR RF-ablation for the management of painful vertebral bone metastases

08:20 – 09:20

Meet the Expert: P. Bernecker

Current controversies in calcium and vitamin D supplementation

09:20 – 09:50 Coffee Break
09:50 – 11:50

Session 6
Oral presentations – translational and clinical research

Chairs: P. Bernecker, L. Hofbauer

S06.1
B. Misof: Differences in osteocyte lacunar properties and bone matrix mineralization in high versus low bone turnover adult patients with CKD-MBD
S06.2
P. Roschger: Elevated bone matrix mineralization in a case of Nasu-Hakola disease
S06.3
L. Pollak: Detection of Regional Bone Loss of the Spine in Patients with Type II Diabetes using a 3-D Atlas Model
S06.4
X. Feichtinger: Multiple Fractures: Fracture patterns, fracture probability and most associated regions.
S06.5
R. Wakolbinger: Bone microarchitecture and bone remodeling in hepatic cirrhosis
S06.6
H. Resch: Hypophosphatasia: Gene analysis and clinical symptoms?
S06.7
M. Papageorgiou: Muscle mass indices and incident osteoporosis in 149,166 postmenopausal women
S06.8
Z. Bertalan: Using deep learning for the prediction of knee osteoarthritis incidence: data from the Osteoarthritis Initiative (OAI) and the Multicenter Osteoarthritis Study (MOST)
S06.9
P. Khashayar: PoCOsteo: PoC in-office device for fracture risk prediction
S06.10
F. Beck: Consolidation of bone grafts in the vertical course of maxillary sinus floor augmentations (MSFA) in human biopsies

12:00 – 13:00 Lunch Break
13:00 – 14:00

CEE Osteoporosis Summit Working Group

Chair: H. Resch, G. Holzer

K. Árvai: Effect of ovariectomy and selective estrogen receptor beta agonist treatment on gene expression of rat bone and bone marrow
E. Czerwinski: Correlation of fractures, BMD and TBS in postmenopausal women
V. Povoroznyuk: Sex Hormones Interaction with Trabecular Bone Score and Mineral Density in Men
M.Kužma: Non-invasive DXA-derived bone structure assessment of acromegaly patients (results of the cross-sectional study)

13:00 – 14:00

Meet the Expert: M.Rauner

Bone Phenotyping

13:00 – 14:00

Guided Poster Session 2

14:00 – 15:00

CEE Osteoporosis Summit Working Group

Chair: H. Resch, G. Holzer

K. Árvai: Effect of ovariectomy and selective estrogen receptor beta agonist treatment on gene expression of rat bone and bone marrow
E. Czerwinski: Correlation of fractures, BMD and TBS in postmenopausal women
V. Povoroznyuk: Sex Hormones Interaction with Trabecular Bone Score and Mineral Density in Men
M.Kužma: Non-invasive DXA-derived bone structure assessment of acromegaly patients (results of the cross-sectional study)

14:00 – 14:30 Coffee Break
14:30 – 16:15

Session 7
Biomaterials, Endoprostheses

Chair: A.M. Weinberg, A. Kurth

S07.1

14:30-15:00
K. Åkesson: Bone healing and anchorage of bone implants – can drugs enhance biology?
Oral presentations from selected abstracts:

S07.2
N. Grün: Evaluation of a lean MgZnCa alloy in an osteoporotic rat model
S07.3
P. Steinbauer: Adhesion motifs for bone blue applications
S07.4
D. Marolt: Human induced pluripotent stem cells-based strategies for bone tissue engineering and regeneration during aging
S07.5
G. Magrin: Physical and mechanical properties of composite scaffolds with or without collagen impregnation
S07.6
C. Kampleitner: Hydroxyapatite nanoparticles for bone repair modulate osteoclast differentiation in vitro
S07.7
A. Kurth: TRAP 5b is a bone marker for early detection of implant loosening

16:15-16:30 Concluding Remarks
 
 
 
 
 
 
Programme Overview
Programme for Friday